Shenyang Xingqi Pharmaceutical announces 2025 semi-annual cash dividend

Shenyang Xingqi Pharmaceutical Co., Ltd. announced its 2025 semi-annual equity distribution plan, approved at the second extraordinary general meeting on September 15, 2025. The company will distribute a cash dividend of CNY 7.00 per 10 shares (tax inclusive) to all shareholders, based on a total share capital of 245,348,945 shares. The total cash dividend amounts to CNY 171,744,261.50. No capital reserve will be converted to share capital, nor will bonus shares be issued. The undistributed profit will be carried forward for future distribution.

The equity distribution record date is September 23, 2025, with the ex-dividend and ex-interest date set for September 24, 2025. For shareholders holding shares through Shenzhen-Hong Kong Stock Connect, foreign institutions (including QFII and RQFII), and individuals holding pre-IPO restricted shares, the after-tax dividend is CNY 6.30 per 10 shares. Individual shareholders with post-IPO restricted shares, equity incentive restricted shares, and unrestricted circulating shares will be subject to differentiated individual income tax rates, to be withheld upon share transfer based on holding period.

Cash dividends for A-share shareholders will be distributed by China Securities Depository and Clearing Corporation Limited Shenzhen Branch and deposited directly into their capital accounts via their custodian securities companies on September 24, 2025.